Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jahad Alghamdi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
BMJ Open|January 1, 2021
Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individualsMesnad Alyabsi, Reham Gaid, Ada Alqunaibet, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2024
Descriptive Analysis of Good Clinical Practice Inspection Findings from the Saudi Food and Drug AuthorityOmaima O Arab, Mohammed Aldayan, Khalid Almowaizri, et al.
Saudi Journal of Biological Sciences|November 26, 2019
Eye color prediction using single nucleotide polymorphisms in Saudi populationJahad Alghamdi, Manal Amoudi, Ahmad Ch Kassab, et al.
The International Journal of Neuropsychopharmacology|July 10, 2018
Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization StudyJahad Alghamdi, Sabine Matou-Nasri, Faisal Alghamdi, et al.
Pharmacogenomics|August 23, 2023
Interethnic differences in drug response: projected impact of genetic variations in the Saudi populationAbdullah Alsultan, Abdullah A Alalwan, Bashayer Alshehri, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 2, 2020
Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi ArabiaAbdullah Alsultan, Wael A Alghamdi, Jahad Alghamdi, et al.
Scientific Reports|July 17, 2020
The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohortMaha Al Ammari, Mohammed AlBalwi, Khizra Sultana, et al.
European Journal of Clinical Pharmacology|July 23, 2020
Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trialsJahad Alghamdi, Abdulziz Alqadi, Adel Alharf, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 19, 2024
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA regionMohammed S Alasmari, Salwa Albusaysi, Marwa Elhefnawy, et al.
International Journal of Molecular Sciences|August 12, 2022
Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19Moudhi Almutlaq, Fatmah A Mansour, Jahad Alghamdi, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
BMJ Open|January 1, 2021
Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individualsMesnad Alyabsi, Reham Gaid, Ada Alqunaibet, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2024
Descriptive Analysis of Good Clinical Practice Inspection Findings from the Saudi Food and Drug AuthorityOmaima O Arab, Mohammed Aldayan, Khalid Almowaizri, et al.
Saudi Journal of Biological Sciences|November 26, 2019
Eye color prediction using single nucleotide polymorphisms in Saudi populationJahad Alghamdi, Manal Amoudi, Ahmad Ch Kassab, et al.
The International Journal of Neuropsychopharmacology|July 10, 2018
Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization StudyJahad Alghamdi, Sabine Matou-Nasri, Faisal Alghamdi, et al.
Pharmacogenomics|August 23, 2023
Interethnic differences in drug response: projected impact of genetic variations in the Saudi populationAbdullah Alsultan, Abdullah A Alalwan, Bashayer Alshehri, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 2, 2020
Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi ArabiaAbdullah Alsultan, Wael A Alghamdi, Jahad Alghamdi, et al.
Scientific Reports|July 17, 2020
The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohortMaha Al Ammari, Mohammed AlBalwi, Khizra Sultana, et al.
European Journal of Clinical Pharmacology|July 23, 2020
Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trialsJahad Alghamdi, Abdulziz Alqadi, Adel Alharf, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 19, 2024
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA regionMohammed S Alasmari, Salwa Albusaysi, Marwa Elhefnawy, et al.
International Journal of Molecular Sciences|August 12, 2022
Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19Moudhi Almutlaq, Fatmah A Mansour, Jahad Alghamdi, et al.
Pageof 3